BIOMARIN PHARMACEUTICAL INC Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for May 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Grant | A | 0.00 | 4,300 | 0 | 22,915 | 18.6 K to 22.9 K (+23.10 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,300 | 0 | 17,940 | 13.6 K to 17.9 K (+31.52 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Grant | A | 0.00 | 4,300 | 0 | 84,340 | 80 K to 84.3 K (+5.37 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 4,300 | 0 | 23,280 | 19 K to 23.3 K (+22.66 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | HOMBACH ROBERT J. | Director | Grant | A | 0.00 | 4,300 | 0 | 16,210 | 11.9 K to 16.2 K (+36.10 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 4,300 | 0 | 51,968 | 47.7 K to 52 K (+9.02 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 4,300 | 0 | 51,968 | 47.7 K to 52 K (+9.02 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 4,300 | 0 | 42,840 | 38.5 K to 42.8 K (+11.16 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | Dere Willard H | Director | Grant | A | 0.00 | 4,300 | 0 | 17,720 | 13.4 K to 17.7 K (+32.04 %) |
May 29 2020 | BMRN | BIOMARIN PHARMACEU ... | ANDERSON ELIZABETH M | Director | Grant | A | 0.00 | 4,300 | 0 | 8,790 | 4.5 K to 8.8 K (+95.77 %) |
May 12 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 20,000 | 430,200 | 0 | |
May 12 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.72 | 20,000 | 1,834,400 | 298,552 | 318.6 K to 298.6 K (-6.28 %) |
May 12 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 20,000 | 430,200 | 318,552 | 298.6 K to 318.6 K (+6.70 %) |
May 06 2020 | BMRN | BIOMARIN PHARMACEU ... | Guyer Charles Greg | EVP, Chief Technica ... | Option Exercise | A | 90.36 | 64,150 | 5,796,594 | 64,150 | |
May 06 2020 | BMRN | BIOMARIN PHARMACEU ... | Guyer Charles Greg | EVP, Chief Technica ... | Grant | A | 0.00 | 35,040 | 0 | 35,040 | 0 to 35 K |
May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 5,000 | 107,550 | 20,000 | |
May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 4,000 | 86,040 | 25,000 | |
May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.00 | 5,000 | 440,000 | 298,552 | 303.6 K to 298.6 K (-1.65 %) |
May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 5,000 | 107,550 | 303,552 | 298.6 K to 303.6 K (+1.67 %) |
May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.38 | 4,000 | 357,520 | 298,552 | 302.6 K to 298.6 K (-1.32 %) |
May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 4,000 | 86,040 | 302,552 | 298.6 K to 302.6 K (+1.34 %) |
May 05 2020 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 62.59 | 339 | 21,217 | 298,552 | 298.2 K to 298.6 K (+0.11 %) |
May 04 2020 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 89.38 | 12,504 | 1,117,608 | 65,677 | 78.2 K to 65.7 K (-15.99 %) |
May 04 2020 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 62.59 | 339 | 21,217 | 78,181 | 77.8 K to 78.2 K (+0.44 %) |
May 04 2020 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 89.38 | 12,504 | 1,117,608 | 65,677 | 78.2 K to 65.7 K (-15.99 %) |
May 04 2020 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 62.59 | 339 | 21,217 | 78,181 | 77.8 K to 78.2 K (+0.44 %) |